Clinical Trials Logo
  1. Home
  2. Epilepsy
  3. NCT05008354
  4. Details
NCT05008354 Clinical Trial

Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam

Epilepsy Clinical Trial

— EPYLEB  

Official title:
Investigation of Pyridoxine Effect on Behavioral Adverse Events of Levetiracetam in Adult Patients With Epilepsy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05008354
Other study ID # 5238
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date October 1, 2020
Est. completion date September 1, 2021

Study information
Verified date March 2022
Source Mazandaran University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a two-arm parallel group randomized double-blind placebo-controlled trial with the aim of Investigating pyridoxine effect on behavioral side effects of levetiracetam in adult patients with epilepsy.

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date September 1, 2021
Est. primary completion date September 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age=18 years - Patients with epilepsy - Patients who are treated by levetiracetam (Levebel, Cobel darou) in recent month - Complaint of behavioral problem - Patient's consent for participation Exclusion Criteria: - History of known psychiatric disease - Pregnancy - Incidence of psychotic side effects including hallucination, psychosis, suicidal idea or attempt - Treatment with psychiatric medications - Alcohol or drug abuse - Mental retardation to the degree that intervenes comprehension and response to questionnaire

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Pyridoxine
Pyridoxine tablet 40mg once daily
• Placebo
Placebo tablet once daily

Locations
Country Name City State
Iran, Islamic Republic of Bu Ali Sina Hospital Sari Mazandaran

Sponsors (2)
Lead Sponsor Collaborator
Nasim Tabrizi Mazandaran University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Behavioral side effects Behavioral side effects are measured by SCL-90-R questionnaire 3 weeks
See also
  Status Clinical Trial Phase
Completed NCT04595513 - Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Phase 1/Phase 2
Completed NCT02909387 - Adapting Project UPLIFT for Blacks in Georgia N/A
Completed NCT05552924 - Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients N/A
Terminated NCT01668654 - Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS Phase 3
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT03994718 - Creative Arts II Study N/A
Recruiting NCT04076449 - Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Completed NCT00782249 - Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Active, not recruiting NCT06034353 - Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients N/A
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Not yet recruiting NCT05559060 - Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
Completed NCT02977208 - Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use Phase 4
Completed NCT02952456 - Phenomenological Approach of Epilepsy in Patients With Epilepsy
Completed NCT02646631 - Behavioral and Educational Tools to Improve Epilepsy Care N/A
Recruiting NCT02539134 - TAK-935 Multiple Rising Dose Study in Healthy Participants Phase 1
Completed NCT02491073 - Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL) N/A
Terminated NCT02757547 - Transcranial Magnetic Stimulation for Epilepsy N/A
Completed NCT02970396 - Self-management for People With Epilepsy and a History of Negative Health Events N/A